Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tekmira and Protiva complete business combination
As part of the business combination, a $10 million private placement with Alnylam Pharmaceuticals and an affiliate of F Hoffman-La Roche has also been completed at a price
As part of the business combination, a $10 million private placement with Alnylam Pharmaceuticals and an affiliate of F Hoffman-La Roche has also been completed at a price
The JZP-6 Phase III clinical trial program includes two randomized, double-blind, placebo-controlled studies. The first study has completed enrollment of 550 fibromyalgia patients at 65 centers in the
Prime Healthcare also has entered into a definitive agreement to acquire two additional Tenet hospitals in California – 167-bed Garden Grove Hospital Medical Center and 64-bed San Dimas
The products acquired consist of the QuickCat thrombus aspiration catheter, ThromCat thrombectomy device and SafeCross products used to treat chronic total occlusions. John Schulte, Spectranetics’s president and CEO,
Each unit consists of one common share of Sonomax and one common share purchase warrant. Each warrant entitles the holder thereof to purchase one additional common share at
Lenalidomide was intended for the treatment of patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality. The marketing
Under terms of the agreement, Santen receives rights to develop and commercialize sirolimus for ocular diseases and conditions in Japan and Asia. MacuSight retains development and commercialization rights
This open-label, dose-escalation Phase I study in patients with solid tumors which are refractory to standard-of-care therapies is being conducted at the UCLA Jonsson Cancer Center in Los
Data from the study showed that TriLipix in combination with rosuvastatin met its primary endpoints with significantly greater improvements in HDL and triglycerides compared to rosuvastatin alone, and
This improvement in survival was observed across all histological subtypes, patient performance status, age groups, previous smoking history, and gender. The pivotal, multinational study known as Flex was